BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2568804)

  • 1. Physicochemical properties and general pharmacology of the nonionic dimer iotrolan.
    Mützel W; Press WR; Weinmann HJ
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():28-32. PubMed ID: 2568804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to iotrolan after subarachnoid injection in animals.
    Press WR; Mützel W; Schöbel C
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():126-33. PubMed ID: 2568780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and biochemical pharmacology of iopromide.
    Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():11-7. PubMed ID: 6195966
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.
    Nauert C; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():82-7. PubMed ID: 2568814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preclinical evaluation of iotrolan as a contrast medium for angiography and urography].
    Miyazawa T; Murayama C; Uchimoto R; Fritz-Zieroth B
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1287-98. PubMed ID: 1437534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrheologic effects of iotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media.
    Nauert C; Langer M; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():40-5. PubMed ID: 2568806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
    Scholz P; Weinmann HJ; Mützel W; Staks T
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical-pharmacologic properties of iohexol.
    Mützel W; Siefert HM; Speck U
    Acta Radiol Suppl; 1980; 362():111-5. PubMed ID: 6168168
    [No Abstract]   [Full Text] [Related]  

  • 10. Organ-specific and general tolerance of iotrolan 280 after intravenous administration: phase I study in healthy volunteers.
    Staks T; Seifert W; Wenzel-Hora BI; Fuhrmeister A
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():33-8. PubMed ID: 2568805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA; Pfennig D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iotrolan-300 versus Iopamidol-300 in hysterosalpingography].
    Schulz-Wendtland R; Bauer M; Henne KW
    Aktuelle Radiol; 1991 Sep; 1(5):256-8. PubMed ID: 1751562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol.
    Heinrich M; Schneider G; Grgic A; Humke U; Kramann B; Uder M
    Invest Radiol; 2004 Jul; 39(7):406-12. PubMed ID: 15194911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography.
    Ringel K; Klotz E; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():153-7. PubMed ID: 2568784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthrography with iotrolan: double-blind comparison between nonionic, monomeric (iohexol 300) and nonionic, dimeric (iotrolan 300) contrast media.
    Schmidt M; Papassotiriou V
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():182-9. PubMed ID: 2568791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
    Hagen B; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electron-beam tomographic imaging of the coronary arteries: an experimental comparison between monomeric and dimeric x-ray contrast media].
    Taupitz M; Wagner S; Schuhmann-Giampieri G; Baumann S; Wolf KJ; Finke I; Hamm B
    Rofo; 1997 Jan; 166(1):3-7. PubMed ID: 9072100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI; Potthoff PC; Jänicke UA
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():148-52. PubMed ID: 2568783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonionic dimer: development and initial testing of an intrathecal contrast agent.
    Sovak M; Ranganathan R; Speck U
    Radiology; 1982 Jan; 142(1):115-8. PubMed ID: 6895557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of iohexol on clotting, fibrinolysis, complement and kallikrein system.
    Schulze B; Beyer HK; Barth V; Tremmel K; Borst U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():18-23. PubMed ID: 6139074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.